That is why I agree with Mesoblast undertaking another phase 3 COVID-19 ARDS trial as long as it is funded by anyone else but us ... the NIH; a new partner; a philanthropist ... literally anyone else but us - we don't have the spare cash and I am not supportive of a CR at these levels !
There is also a new variant in France and there is bound to be others so I think we could get some valuable data from this additional phase 3 trial and of course if the PE's are met well it would leave the door open for at the very least an EUA ?
https://www.independent.co.uk/news/world/europe/ihu-covid-variant-france-mutations-b1986953.html
Namita Singh
1 hour ago
IHU: New Covid variant with 46 mutations worries experts in France
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-8
-
- There are more pages in this discussion • 898 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |